Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07185750

Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients

Juvenile idiopathic arthritis (JIA) is the primary rheumatic disease reported to affect the pediatric population. Research suggests that parents' thoughts and feelings about their child's pain, specifically with JIA diagnosis, may influence treatment compliance. Considering that this situation may also affect children's adherence to treatment, the identification and management of parents' catastrophizing of pain is emphasized as important in improving treatment outcomes. This study aimed to examine the biopsychosocial characteristics of parents of children diagnosed with JIA according to their reported catastrophizing of pain.

Recruiting

Interested in participating?

Request Info

Key information

Age range

7 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hacettepe University

Çankaya, Ankara, Turkey (Türkiye)

Location status: Recruiting

Location contact

Orkun Tüfekçi, PT, PhD(c)

CONTACT

[email protected]

05319502648

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between 7-18 years of age
  • Diagnosed with JIA
  • Individuals who volunteer to participate in the study will be included.

Exclusion criteria

  • Having advanced heart/lung/liver/kidney disease, neurological disease, or malignancies
  • Having undergone major orthopedic surgery
  • Not volunteering to participate in the study

Treatment and study plan

Questionnaire application for JIA cases and their parents

Other

Scales will be applied to cases diagnosed with JIA and their parents

Primary outcomes

  1. Pain Catastrophizing Scale-Parent (PCS-P)

    Time frame: Baseline

    It is assessed using a 5-point Likert scale ranging from 0 (never) to 4 (always) and consists of 13 items. Similar to the child questionnaire, it assesses 3 domains: rumination, magnification, and helplessness. A total score between 0 and 52 is obtained; higher scores reflect a higher level of catastrophizing in parents.

  2. Pain Catastrophizing Scale-Children (PCS-C)

    Time frame: Baseline

    Consists of 13 items that describe the different thoughts and feelings children may experience when they feel pain. The questionnaire measures three domains: rumination, magnification, and helplessness. All items are rated on a 5-point Likert scale ranging from 0 (never) to 4 (always). Higher scores indicate more catastrophic pain beliefs. The total score ranges from 0 to 52.

Secondary outcomes

  1. Juvenile Arthritis Biopsychosocial Scale-JAB-Q-Patient

    Time frame: Baseline

    It is a patient/parent-centered measurement method that helps assess the patient's biopsychosocial aspects, such as disease activity, posture, functional and psychosocial status, fatigue, and school performance. The results from the questions are used to assess the functional status of children, while their psychosocial status is recorded based on their answers to 21 questions (ranging from 0 to 358). A high score indicates a poor psychosocial status.

  2. Childhood Health Assessment Questionnaire (CHAQ)

    Time frame: Baseline

    The CHAQ assesses the functional abilities of children diagnosed with rheumatic diseases in their daily living activities. It consists of eight subscales (dressing and personal care, standing up, eating, walking, body care, reaching, grasping, activities) (0-3) and also assesses pain and general well-being using a visual analog scale (0-100). A high score indicates low functionality.

  3. Juvenile Arthritis Quality of Life Questionnaire (JAQQ)

    Time frame: Baseline

    It consists of 74 items covering various health domains, including physical functioning, emotional well-being, and general symptoms. The items are divided into four dimensions related to the child's quality of life: gross motor function (GMF), fine motor function (FMF), psychosocial function (PF), and systemic or general symptoms (SGS). Each domain is scored on a Likert-type scale from 1 to 7; higher scores indicate poorer health-related quality of life. There is also a "not applicable to me" option for the items. The scale also includes a pain measurement (10 cm Visual Analog Scale (VAS)) to assess pain, but this score is not included in the total score.

  4. Juvenile Arthritis Biopsychosocial Scale-JAB-Q-Family

    Time frame: Baseline

    JAB-Q is a multidimensional questionnaire and a parent (family) form. Developed in Turkish by Ünal and colleagues, the questionnaire is completed by one of the child's parents. The family form evaluates the parents' biopsychosocial status from their own perspective and provides scores ranging from 0 to 102. Higher scores indicate a worse biopsychosocial status.

  5. Child and Adolescent Scale of Participation (CASP)

    Time frame: Baseline

    This is a 20-question survey that evaluates the community participation of children and adolescents in school, neighborhood, and local settings. The survey is divided into four sections: 6 questions about home participation, four questions on neighborhood and community involvement, five questions regarding school participation, and five questions on home and community engagement. It is rated on a scale of "expected for their age (full participation), somewhat limited, very limited, unable to participate, and inapplicable." The survey is completed by the child's family or primary caregiver. The person filling out the questionnaire is asked to select the answer that best describes the child's level of participation. The assessment is scored out of 100 points, with higher scores reflecting a greater level of participation.

Study contacts

Contact information is provided by the study sponsor or research team.

Orkun Tüfekçi, PT, PhD(c)

CONTACT

[email protected]

5319502648

Sponsors and collaborators

Lead sponsor

Hacettepe University

Other

Registry information

Official study title

Investigation of Biopsychosocial Characteristics According to Catastrophizing of Pain Reported by Parents in Patients Diagnosed With JIA

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Sep 22, 2025
Registry last updated
Sep 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.